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The Pharmacogenetics of Body Odor:
As Easy as ABCC?
Sara Brown1
ABCC11 genotype affects apocrine secretory cell function and determines
individual body odor phenotype. Rodriguez et al. have applied genetic epide-
miology using predetermined phenotype data to demonstrate an association
between a single-nucleotide polymorphism (rs17822931) and the human behavior
of deodorant application. Individuals with the ABCC11 genotype predicting a
nonodorous phenotype report a significantly lower frequency of deodorant use.
Journal of Investigative Dermatology (2013) 133, 1709–1711. doi:10.1038/jid.2013.14
Personalized medicine
The combination of knowledge from the
fields of cell biology, molecular genet-
ics, and epidemiology creates a power-
ful tool with which to investigate
interactions between human genotype
and the requirement for, or response to,
treatment. Such personalized medicine
may be applied to optimize our use
of pharmacological interventions. The
report in this issue, Rodriguez et al.
(2013), relates to the influence of one
genetic variant on body odor. The
research team has built on knowledge
of genetic determinants of apocrine cell
biology with the addition of genetic
epidemiology, to describe a novel link
between genetic variation and human
behavior.
The ATP-binding cassette, subfamily C,
member 11 (ABCC11)
ABCC11 (OMIM*607040), a gene on
chromosome 16q21.1, encodes a pro-
tein from the ATP-binding cassette
super-family with sequence homology
to multidrug-resistant proteins (RefSeq
Summary NM_145186); it includes two
ATP-binding domains and two
transmembrane regions (Tammur et al.,
2001). Multiple alternatively spliced
variants are expressed in different
human tissues, including the liver,
gastrointestinal tract, kidney, breast,
and skin (Human Protein Atlas, 2012).
The ABCC11 protein is involved in the
transport of small molecules across
apical membranes, in a process that is
most well characterized in apocrine
secretory cells (Martin et al., 2010),
(Figure 1). A common nonsynonymous
single-nucleotide polymorphism (SNP)
in ABCC11 and also a rarer 27-base-
pair deletion are responsible for the
determination of human ear wax
type with a Mendelian pattern of
inheritance (Yoshiura et al., 2006).
Individuals carrying the AA genotype
of SNP rs17822931 have nonfunctional
ABCC11 resulting in dry or ‘‘rice-bran’’
ear wax, whereas those carrying the
dominant G allele (genotype GA or
GG) produce functional ABCC11
protein, resulting in wet or ‘‘honey
type’’ ear wax. The rs17822931 SNP
genotype also largely determines the
phenotype of human body odor and
this follows a surprisingly simple
pattern of Mendelian inheritance, as
functional ABCC11 is essential for the
biochemical formation of human
axillary odor (Martin et al., 2010).
Applied genetic epidemiology
The Avon Longitudinal Study of Parents
and Children (ALSPAC) is a large popu-
lation-based epidemiological study from
the southwest of England. ALSPAC has
made a significant contribution to the
investigation of genetic and environ-
mental factors in disease since its launch
in 1991 (Pearson, 2012). Rodriguez
et al. have made use of the resource
available in ALSPAC to test the
hypothesis that deodorant usage is
determined by ABCC11 genotype.
The group studied more than 6,000
mothers, over 7,000 children, and 5,000
male partners (presumed to be the chil-
dren’s fathers) for whom ABCC11 geno-
type and body odor phenotype data
were available. One limitation that is
inherent to such large epidemiological
studies is that data collected prospec-
tively are necessarily limited by the use
of predetermined questionnaires. The
quantification of deodorant use was
based on self-reported frequency of
deodorant application by males during
their partner’s pregnancy and by
mothers 8 months after birth, each in
response to a question under the
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heading of ‘‘chemicals in your environ-
ment’’. This context may have resulted
in ascertainment bias. Similarly, as no
data were available for how often the
parents washed themselves, the quanti-
fication of ‘‘hygiene’’ was defined from
available data. The mother’s hygiene
was ascertained by how often she
washed her child and the partner’s
hygiene by how often he helped with
domestic washing of clothes and cook-
ing utensils. Finally, the ABCC11 geno-
types of male partners could not be
determined by direct DNA testing, but
were partially inferred from the child’s
genotype. However, notwithstanding
these limitations, the data demonstrate
a highly significant association between
the rs17822931 genotype and deo-
dorant usage (w2 P¼3.7 10 20)
comparing observed with expected gen-
otype frequencies across categories of
self-reported deodorant use in 6,495
women. Women of the odiferous GG
genotype are B10 times more likely to
report daily deodorant usage than those
of the non-odiferous AA genotype.
Importantly, as the prevalence of differ-
ent ABCC11 genotypes varies between
populations, the authors have demon-
strated an association of rs17822931
genotype with deodorant use in both
white and non-white subgroups as evi-
dence that the observed association is
not simply a manifestation of population
stratification.
Rodriguez et al. discuss several other
possible confounding factors, but the
most difficult issue to resolve is whether
the respondents are reporting deodorant
or antiperspirant use. Deodorants are
designed to counteract body odor,
whereas antiperspirants primarily reduce
sweat production, but respondents may
not have made this distinction in their
report of ‘‘deodorant’’ usage. The distinc-
tion is theoretically important because
the authors’ hypothesis is based on a
cellular mechanism of odor production.
However, most antiperspirants also con-
tain a fragranced deodorant component,
thus the distinction is not clear-cut and
the significant result is present, despite
this confounder. Hence, this study illus-
trates that the use of pre-existing data can
be applied to demonstrate the influence
of a SNP on population behavior, even
with sub-optimal phenotype and geno-
type ascertainment.
Gene–environment interaction and
gender differences
This study demonstrates an interesting
perspective on gene–environment inter-
action. Individual ABCC11 genotype
can be seen to affect the personal
environment in terms of odor and influ-
encing exposure to deodorant.
Some notable gender differences
were observed and are reported tactfully.
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Figure 1. Expression sites and known functions of the ATP-binding cassette C11 protein. Alternatively spliced variants of the ATP-binding cassette C11 protein
(ABCC11) are expressed in different human tissues and have a role in the transport of small molecules across apical membranes. ABCC11 function and pathology
is best characterized in the apocrine secretory cells of breast tissue, cutaneous sweat glands, and auditory ceruminous glands. 1Toyoda et al. (2010); 2Miura et al.
(2007); 3Martin et al. (2010); 4Yoshiura et al. (2006).
Clinical Implications
 ABCC11 genotype determines need for deodorant use.
 A subset of the population (B1.8% of white Europeans) do not require
deodorant for the control of body odor.
 The combination of molecular biology and genetic epidemiology can
provide novel insights of relevance to public health.
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A total of 83% of men state that they use
deodorants on most days or daily com-
pared with a significantly higher proportion
(93%) of women who report daily usage.
Conversely, 4.7% of women with a geneti-
cally determined tendency to produce
body odor use deodorant less than once
a week compared with 13% of ‘‘genotypi-
cally odorous’’ men. The study authors did
not find statistical evidence of assortative
mating based on rs17822931 genotype.
Implications for pharmacogenomics
Although the study of body odor may
perhaps be viewed as a relatively trivial
concern, the sale of deodorants and anti-
perspirants represents an annual market
share of over $1.9 billion in the United
States (http://www.marketresearch.com/
map/prod/1209574.html) and appro-
ximately d548 million in the United
Kingdom, where an estimated 94% of
women and 87% of men are said to use
these products regularly (http://store.
mintel.com/deodorants-and-bodysprays-uk-
february-2011). The finding by Rodriguez
et al. that a proportion of individuals use
deodorant unnecessarily implies that the
market could be reduced, with possible
economic effects and environmental bene-
fits. However, among white Europeans, this
‘‘unnecessary’’ use of deodorant relates to
only about 1.2% of the population (i.e.,
78% of the 1.6% AA homozygous ‘‘geno-
typically nonodorous’’ individuals). There-
fore, it is not likely to have a large impact
on the deodorant/antiperspirant market.
This study illustrates an unusually sim-
ple example of pharmacogenetics.
Rodriguez et al. (2013) were careful to
compare additive and recessive models
of effect for ABCC11 genotype on deo-
dorant use. The additive model assumes
a step-wise change in phenotype when
comparing genotypes GG- GA- AA,
whereas a recessive model assumes that
the phenotype for genotypes GG and GA
are the same, but different from the
phenotype of AA. The results of associa-
tion analyses were generally similar
using additive and recessive models,
but there was some evidence of a hetero-
zygote effect, consistent with a gene-
tically determined dose effect of axillary
odorant production.
The genotype–phenotype association
between ABCC11 and body odor follows
a Mendelian pattern of inheritance, but
this is unlikely to be the case for the
majority of pharmacogenomic interac-
tions of clinical relevance (Crews et al.,
2012). It is predicted that multiple single-
nucleotide variants, as well as copy
number variations and epigenetic modifi-
cations affecting multiple genes and path-
ways, are likely to form more complex
interactions in the majority of derma-
tological conditions. While progress is
being made, the field of pharmaco-
genomics remains a significant challenge
to our understanding and its appli-
cation to patient care is an ongoing work.
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The Macrophage: A New Factor in
UVR-Induced Melanomagenesis
Tao Wang1 and Meenhard Herlyn1
UVR is one of the major risk factors for melanoma development. However, the
mechanisms by which UVR leads to the development of melanoma are not fully
understood. Handoko et al. (this issue) explicitly indicate that macrophages
are essential for UVR-induced melanocyte proliferation and migration using
a neonatal mouse model. Although the functions and mechanisms of
macrophages on melanoma development must be investigated further, the link
between macrophages and melanocyte responses is striking, suggesting that
macrophages might be a target for preventing UVR-induced melanoma.
Journal of Investigative Dermatology (2013) 133, 1711–1713. doi:10.1038/jid.2013.93
Epidemiological studies suggest that
there is a correlation between high
levels of UVR exposure, particularly
during childhood, and the risk of deve-
loping melanoma (Whiteman et al.,
2001; Gandini et al., 2005; Kanavy
and Gerstenblith, 2011). UVR exposure
induces DNA damage in human
melanocytes, causing mutations that
are associated with the development of
melanoma (Kanavy and Gerstenblith,
2011). Next-generation sequencing of
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